<DOC>
	<DOCNO>NCT01074723</DOCNO>
	<brief_summary>We , investigator , aim study , vitro vivo , bioavailability add b-cryptoxanthin phytosterols evaluate vivo effect biochemical marker bone remodelling cardiovascular risk . Specifically , 1 ) ass stability food bioavailability b-cryptoxanthin presence phytosterols ( absorption modifier ) use complementary approach ; vitro vivo study ; 2 ) study post-menopausal woman ( target group ) biological effect ( bioefficacy ) associate regular consumption modify milk-based fruit beverage ( contain b-cryptoxanthin phytosterols ) assess change biochemical marker bone turnover cardiovascular risk .</brief_summary>
	<brief_title>B-cryptoxanthin Phytosterols Bone Remodeling Cardiovascular Risk Factors</brief_title>
	<detailed_description />
	<criteria>Postmenopausal woman , 4560 year old Dieting Food allergy ( component provide ) Hormone replacement therapy Cholesterol lower drug , antiresorptive anabolic bone drug Calcium vitamin D supplement Soybean product Vitaminmineral supplement Fibre supplement Commercially available enrich food ( i.e . w3 , phytosterols , carotenoid , ... )</criteria>
	<gender>Female</gender>
	<minimum_age>45 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>February 2014</verification_date>
	<keyword>b-cryptoxanthin</keyword>
	<keyword>cholesterol</keyword>
	<keyword>bone marker</keyword>
	<keyword>Osteoporosis</keyword>
	<keyword>cardiovascular risk</keyword>
	<keyword>post-menopausal woman</keyword>
</DOC>